Reducing the sale of marijuana to intoxicated customers
Policy and Training Intervention in Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers
This study is looking at ways to help marijuana stores in Oregon make sure they don’t sell to people who are already high, by training staff to spot signs of intoxication and follow the rules, so everyone stays safe and responsible.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Klein Buendel, INC. NIH-funded |
| Lab location | 1 site (Golden, United States) |
| Project ID | NIH-10932385 on NIH RePORTER |
What this research studies
This research investigates how to prevent the sale of marijuana to customers who are already intoxicated, particularly in the context of new recreational marijuana markets. It focuses on implementing a policy and training intervention in Oregon, where laws prohibit selling to obviously intoxicated individuals. The approach includes training store personnel to recognize signs of intoxication and comply with state regulations, alongside efforts to enhance enforcement of these laws. The study will assess the effectiveness of these interventions through evaluations at various marijuana retail locations.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who frequent recreational marijuana dispensaries and may be affected by policies regarding intoxicated sales.
Not a fit: Patients who do not consume marijuana or are not involved in recreational marijuana markets may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer marijuana sales practices and reduce incidents of impaired driving and related harms.
How similar studies have performed: While this approach is innovative, similar interventions targeting responsible sales practices in alcohol and other substances have shown promise in reducing related harms.
Where this research is happening
Golden, United States
- Klein Buendel, INC. — Golden, United States (Active)
Researchers
- Principal investigator: Woodall, W Gill — Klein Buendel, INC.
- Study coordinator: Woodall, W Gill
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.